Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

India: DCGI approval for trialling of nasal COVID-19 vaccine

January 28, 2022 Medical Communications

The Drugs Controller General of India (DCGI) has given permission to Bharat Biotech to conduct clinical trials for the use …
News

The downfall of COVID-19 lies in new generation anti-viral drugs, says WHO

January 28, 2022 Medical Communications

In a BBC News interview, WHO shared their views against easing pandemic restrictions, as new variants flare up anywhere until …
News

EU health ministers consider fourth COVID-19 vaccine dose

January 21, 2022 Medical Communications

European Union health ministers will try to find a common line on Friday over a potential fourth dose of COVID-19 …
News

Amid plans to ease COVID restrictions, dialysis patients remain vulnerable to Omicron

January 21, 2022 Medical Communications

As the government in England relaxes COVID-19 restrictions, new data from the Francis Crick Institute raise concerns over the impact …
News

Artificial pancreas may prove life-changing for young children with diabetes

January 21, 2022 Medical Communications

Cambridge researchers have developed an artificial pancreas which may beat standard treatment in controlling Type 1 diabetes in young children. …
News

Clover reveals positive data from Phase II/III COVID-19 vaccine trial

January 21, 2022 Medical Communications

Clover Biopharmaceuticals has announced that final efficacy data from SPECTRA, a global Phase II/III clinical trial into its COVID-19 vaccine …
News

AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins

January 14, 2022 Medical Communications

AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …
News

South Africa study shows J&J booster 85% effective against Omicron hospitalisation

January 14, 2022 Medical Communications

The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …
News

First melanoma test to offer reassurance of low risk of cancer spread

January 14, 2022 Medical Communications

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …
News

WHO recommend two new COVID-19 treatments

January 14, 2022 Medical Communications

WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …
News
mufid-majnun-oi20ehignd4-unsplash

Canada to procure 20,000 doses of GSK COVID-19 antibody therapy

January 7, 2022 Medical Communications

GlaxoSmithKline Plc. has shared that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab, …
News

Judge orders FDA to produce Pfizer safety data in eight months

January 7, 2022 Medical Communications

A federal judge has ordered the FDA to make public tens of thousands of more pages on the data it …
News

J&J COVID-19 vaccine shows protection against breakthrough infection for up to six months

January 7, 2022 Medical Communications

J&J have announced new results from the largest study to date on the durability of COVID-19 vaccines in the US. …
News

Neurimmune and AstraZeneca collaborate to develop human monoclonal antibody

January 7, 2022 Medical Communications

Neurimmune AG announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca Rare Disease …
News
nice

NICE recommends combination treatment for patients with multiple myeloma

December 24, 2021 Medical Communications

NICE has recommended the use of Darzalex (daratumumab) in combination with Velcade (bortezomib), thalidomide and dexamethasone (DVTd) as induction and …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026